Lovett Michael, Lee Kyongbum, Edwards Aurelie, Kaplan David L
Department of Biomedical Engineering, Tufts University, Medford, Massachusetts 02155, USA.
Tissue Eng Part B Rev. 2009 Sep;15(3):353-70. doi: 10.1089/ten.TEB.2009.0085.
Tissue engineering is currently limited by the inability to adequately vascularize tissues in vitro or in vivo. Issues of nutrient perfusion and mass transport limitations, especially oxygen diffusion, restrict construct development to smaller than clinically relevant dimensions and limit the ability for in vivo integration. There is much interest in the field as researchers have undertaken a variety of approaches to vascularization, including material functionalization, scaffold design, microfabrication, bioreactor development, endothelial cell seeding, modular assembly, and in vivo systems. Efforts to model and measure oxygen diffusion and consumption within these engineered tissues have sought to quantitatively assess and improve these design strategies. This review assesses the current state of the field by outlining the prevailing approaches taken toward producing vascularized tissues and highlighting their strengths and weaknesses.
组织工程目前受到无法在体外或体内充分实现组织血管化的限制。营养物质灌注和物质传输限制问题,尤其是氧气扩散问题,将构建物的发展限制在小于临床相关尺寸的范围内,并限制了其在体内整合的能力。该领域备受关注,因为研究人员采用了多种血管化方法,包括材料功能化、支架设计、微制造、生物反应器开发、内皮细胞接种、模块化组装和体内系统。对这些工程组织内氧气扩散和消耗进行建模和测量的努力旨在定量评估和改进这些设计策略。本综述通过概述生产血管化组织的主要方法并突出其优缺点来评估该领域的当前状况。